Erratum: Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): An open-label, randomised, phase 2 trial (Lancet (2014) 383 (515-23))

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalThe Lancet
Volume383
Issue number9920
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Cite this